Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Asthma

  Free Subscription


Articles published in Respir Med

Retrieve available abstracts of 77 articles:
HTML format
Text format



Single Articles


    October 2017
  1. BAKIRTAS A, Kutlu A, Baccioglu A, Erkekol FO, et al
    Physicians' preference for controller medication in mild persistent asthma.
    Respir Med. 2017;131:236-240.
    PubMed     Text format     Abstract available


  2. LI N, Qiu R, Yang Z, Li J, et al
    Sputum microbiota in severe asthma patients: Relationship to eosinophilic inflammation.
    Respir Med. 2017;131:192-198.
    PubMed     Text format     Abstract available


  3. SCHMIDT O, Petro W, Hoheisel G, Kanniess F, et al
    Real-life effectiveness of asthma treatment with a fixed-dose fluticasone/formoterol pressurised metered-dose inhaler - Results from a non-interventional study.
    Respir Med. 2017;131:166-174.
    PubMed     Text format     Abstract available


  4. FITZGERALD JM, Tavakoli H, Lynd LD, Al Efraij K, et al
    The impact of inappropriate use of short acting beta agonists in asthma.
    Respir Med. 2017;131:135-140.
    PubMed     Text format     Abstract available


  5. ZIERAU L, Walsted ES, Thomsen SF, Backer V, et al
    Response to omalizumab in patients with severe allergic asthma: A real-life study.
    Respir Med. 2017;131:109-113.
    PubMed     Text format     Abstract available


    August 2017
  6. MAHON J, Fitzgerald A, Glanville J, Dekhuijzen R, et al
    Misuse and/or treatment delivery failure of inhalers among patients with asthma or COPD: A review and recommendations for the conduct of future research.
    Respir Med. 2017;129:98-116.
    PubMed     Text format     Abstract available


  7. LEWIS A, Torvinen S, Dekhuijzen PNR, Chrystyn H, et al
    Budesonide + formoterol delivered via Spiromax(R) for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler(R).
    Respir Med. 2017;129:179-188.
    PubMed     Text format     Abstract available


    July 2017
  8. NELSEN LM, Vernon M, Ortega H, Cockle SM, et al
    Evaluation of the psychometric properties of the St George's Respiratory Questionnaire in patients with severe asthma.
    Respir Med. 2017;128:42-49.
    PubMed     Text format     Abstract available


    June 2017
  9. PLOURDE A, Lavoie KL, Raddatz C, Bacon SL, et al
    Effects of acute psychological stress induced in laboratory on physiological responses in asthma populations: A systematic review.
    Respir Med. 2017;127:21-32.
    PubMed     Text format     Abstract available


    May 2017
  10. SCHOR D, Rizzo JA, Medeiros D, Dela Bianca AC, et al
    Home-made spacer as an auxiliary device in administration of beclomethasone via pressurized metered dose inhaler for asthma control. A randomized controlled pragmatic trial.
    Respir Med. 2017;126:52-58.
    PubMed     Text format     Abstract available


  11. NELSEN LM, Kimel M, Murray LT, Ortega H, et al
    Qualitative evaluation of the St George's Respiratory Questionnaire in patients with severe asthma.
    Respir Med. 2017;126:32-38.
    PubMed     Text format     Abstract available


  12. FERRER GALVAN M, Javier Alvarez Gutierrez F, Romero Falcon A, Romero Romero B, et al
    Is the bronchodilator test an useful tool to measure asthma control?
    Respir Med. 2017;126:26-31.
    PubMed     Text format     Abstract available


  13. ADACHI M, Goldfrad C, Jacques L, Nishimura Y, et al
    Corrigendum to "Efficacy and safety comparison: Fluticasone furoate and fluticasone propionate, after step down from fluticasone furoate/vilanterol in Japanese patients with well-controlled asthma, a randomized trial" [Respir. Med. 120 (November 2016)
    Respir Med. 2017;126:25.
    PubMed     Text format    


    April 2017
  14. NADEAU M, Boulay ME, Milot J, Lepage J, et al
    Comparative prevalence of co-morbidities in smoking and non-smoking asthma patients with incomplete reversibility of airway obstruction, non-smoking asthma patients with complete reversibility of airway obstruction and COPD patients.
    Respir Med. 2017;125:82-88.
    PubMed     Text format     Abstract available


  15. RASTOGI D, Jung M, Strizich G, Shaw PA, et al
    Association of systemic inflammation, adiposity, and metabolic dysregulation with asthma burden among Hispanic adults.
    Respir Med. 2017;125:72-81.
    PubMed     Text format     Abstract available


  16. AKIKI Z, Rava M, Diaz Gil O, Pin I, et al
    Serum cytokine profiles as predictors of asthma control in adults from the EGEA study.
    Respir Med. 2017;125:57-64.
    PubMed     Text format     Abstract available


  17. JEONG A, Imboden M, Hansen S, Zemp E, et al
    Heterogeneity of obesity-asthma association disentangled by latent class analysis, the SAPALDIA cohort.
    Respir Med. 2017;125:25-32.
    PubMed     Text format     Abstract available


    March 2017
  18. TIWARI A, Rahman K, Abejie B, Jain VV, et al
    Longer duration of asthma is significantly associated with increased RV/TLC ratio.
    Respir Med. 2017;124:44-48.
    PubMed     Text format     Abstract available


  19. MANSUR AH, Srivastava S, Mitchell V, Sullivan J, et al
    Longterm clinical outcomes of omalizumab therapy in severe allergic asthma: Study of efficacy and safety.
    Respir Med. 2017;124:36-43.
    PubMed     Text format     Abstract available


  20. VON BULOW A, Backer V, Bodtger U, Soes-Petersen NU, et al
    The level of diagnostic assessment in severe asthma: A nationwide real-life study.
    Respir Med. 2017;124:21-29.
    PubMed     Text format     Abstract available


    February 2017
  21. SILVERMAN RA, Hasegawa K, Egan DJ, Stiffler KA, et al
    Multicenter study of cigarette smoking among adults with asthma exacerbations in the emergency department, 2011-2012.
    Respir Med. 2017 Feb 7. pii: S0954-6111(17)30025.
    PubMed     Text format     Abstract available


  22. VEIDAL S, Jeppegaard M, Sverrild A, Backer V, et al
    The impact of dysfunctional breathing on the assessment of asthma control.
    Respir Med. 2017;123:42-47.
    PubMed     Text format     Abstract available


  23. BJERREGAARD A, Laing IA, Poulsen N, Backer V, et al
    Characteristics associated with clinical severity and inflammatory phenotype of naturally occurring virus-induced exacerbations of asthma in adults.
    Respir Med. 2017;123:34-41.
    PubMed     Text format     Abstract available


  24. COCKLE SM, Stynes G, Gunsoy NB, Parks D, et al
    Comparative effectiveness of mepolizumab and omalizumab in severe asthma: An indirect treatment comparison.
    Respir Med. 2017;123:140-148.
    PubMed     Text format     Abstract available


  25. VARSANO S, Segev D, Shitrit D
    Severe and non-severe asthma in the community: A large electronic database analysis.
    Respir Med. 2017;123:131-139.
    PubMed     Text format     Abstract available


  26. TAKAKU Y, Kurashima K, Ohta C, Ishiguro T, et al
    How many instructions are required to correct inhalation errors in patients with asthma and chronic obstructive pulmonary disease?
    Respir Med. 2017;123:110-115.
    PubMed     Text format     Abstract available


    January 2017
  27. ADEYEYE OO, Adewumi TA, Adewuya AO
    Effect of psychological and other factors on quality of life amongst asthma outpatients in Lagos, Nigeria.
    Respir Med. 2017;122:67-70.
    PubMed     Text format     Abstract available


  28. HALLIT S, Raherison C, Waked M, Salameh P, et al
    Validation of asthma control questionnaire and risk factors affecting uncontrolled asthma among the Lebanese children's population.
    Respir Med. 2017;122:51-57.
    PubMed     Text format     Abstract available


    December 2016
  29. CHECKLEY W, Deza MP, Klawitter J, Romero KM, et al
    Identifying biomarkers for asthma diagnosis using targeted metabolomics approaches.
    Respir Med. 2016;121:59-66.
    PubMed     Text format     Abstract available


  30. CHEN JH, Qin L, Shi YY, Feng JT, et al
    IL-17 protein levels in both induced sputum and plasma are increased in stable but not acute asthma individuals with obesity.
    Respir Med. 2016;121:48-58.
    PubMed     Text format     Abstract available


  31. COMARU T, Pitrez PM, Friedrich FO, Silveira VD, et al
    Free asthma medications reduces hospital admissions in Brazil (Free asthma drugs reduces hospitalizations in Brazil).
    Respir Med. 2016;121:21-25.
    PubMed     Text format     Abstract available


    November 2016
  32. ADACHI M, Goldfrad C, Jacques L, Nishimura Y, et al
    Efficacy and safety comparison: Fluticasone furoate and fluticasone propionate, after step down from fluticasone furoate/vilanterol in Japanese patients with well-controlled asthma, a randomized trial.
    Respir Med. 2016;120:78-86.
    PubMed     Text format     Abstract available


  33. JANSSON SA, Axelsson M, Hedman L, Leander M, et al
    Subjects with well-controlled asthma have similar health-related quality of life as subjects without asthma.
    Respir Med. 2016;120:64-69.
    PubMed     Text format     Abstract available


  34. DEL GIACCO SR, Cappai A, Gambula L, Cabras S, et al
    The asthma-anxiety connection.
    Respir Med. 2016;120:44-53.
    PubMed     Text format     Abstract available


  35. LAHELMA S, Vahteristo M, Metev H, Taseva M, et al
    Equivalent bronchodilation with budesonide/formoterol combination via Easyhaler and Turbuhaler in patients with asthma.
    Respir Med. 2016;120:31-35.
    PubMed     Text format     Abstract available


  36. ALI Z, Nilas L, Ulrik CS
    Low risk of adverse obstetrical and perinatal outcome in pregnancies complicated by asthma: A case control study.
    Respir Med. 2016;120:124-130.
    PubMed     Text format     Abstract available


  37. APIKOGLU-RABUS S, Yesilyaprak G, Izzettin FV
    Drug-related problems and pharmacist interventions in a cohort of patients with asthma and chronic obstructive pulmonary disease.
    Respir Med. 2016;120:109-115.
    PubMed     Text format     Abstract available


  38. LARSEN K, Faulkner GE, Boak A, Hamilton HA, et al
    Looking beyond cigarettes: Are Ontario adolescents with asthma less likely to smoke e-cigarettes, marijuana, waterpipes or tobacco cigarettes?
    Respir Med. 2016;120:10-15.
    PubMed     Text format     Abstract available


    October 2016
  39. ARFE A, Blasi F, Merlino L, Corrao G, et al
    Respiratory drugs and macrolides prevent asthma exacerbations: A real-world investigation.
    Respir Med. 2016;119:7-12.
    PubMed     Text format     Abstract available


  40. ENGELKES M, Janssens HM, de Ridder MA, Sturkenboom MC, et al
    Real life data on incidence and risk factors of severe asthma exacerbations in children in primary care.
    Respir Med. 2016;119:48-54.
    PubMed     Text format     Abstract available


  41. ZIERAU L, Gade EJ, Lindenberg S, Backer V, et al
    Coexistence of asthma and polycystic ovary syndrome: A concise review.
    Respir Med. 2016;119:155-159.
    PubMed     Text format     Abstract available


  42. PETHERICK ES, Pearce N, Sunyer J, Wright J, et al
    Ethnic and socio-economic differences in the prevalence of wheeze, severe wheeze, asthma, eczema and medication usage at 4 years of age: Findings from the Born in Bradford birth cohort.
    Respir Med. 2016;119:122-129.
    PubMed     Text format     Abstract available


  43. BRAITHWAITE I, Williams M, Power S, Pilcher J, et al
    Randomised, double-blind, placebo-controlled, cross-over single dose study of the bronchodilator duration of action of combination fluticasone furoate/vilanterol inhaler in adult asthma.
    Respir Med. 2016;119:115-121.
    PubMed     Text format     Abstract available


  44. EFTEKHARI P, Forder PM, Majeed T, Byles JE, et al
    Impact of asthma on mortality in older women: An Australian cohort study of 10,413 women.
    Respir Med. 2016;119:102-108.
    PubMed     Text format     Abstract available


  45. MORI K, Fujisawa T, Inui N, Hashimoto D, et al
    Step-down treatment from medium-dosage of budesonide/formoterol in controlled asthma.
    Respir Med. 2016;119:1-6.
    PubMed     Text format     Abstract available


    September 2016
  46. WESTERHOF GA, de Groot JC, Amelink M, de Nijs SB, et al
    Predictors of frequent exacerbations in (ex)smoking and never smoking adults with severe asthma.
    Respir Med. 2016;118:122-7.
    PubMed     Text format     Abstract available


  47. GRZELA K, Litwiniuk M, Krejner A, Zagorska W, et al
    Increased angiogenic factors in exhaled breath condensate of children with severe asthma - New markers of disease progression?
    Respir Med. 2016;118:119-21.
    PubMed     Text format     Abstract available


  48. DAHL R, Engel M, Dusser D, Halpin D, et al
    Safety and tolerability of once-daily tiotropium Respimat((R)) as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysis.
    Respir Med. 2016;118:102-11.
    PubMed     Text format     Abstract available


  49. KONDLA A, Glaab T, Pedersini R, Lommatzsch M, et al
    Asthma control in patients treated with inhaled corticosteroids and long-acting beta agonists: A population-based analysis in Germany.
    Respir Med. 2016;118:58-64.
    PubMed     Text format     Abstract available


  50. CHAUDHURI R, McSharry C, Heaney LG, Niven R, et al
    Effects of older age and age of asthma onset on clinical and inflammatory variables in severe refractory asthma.
    Respir Med. 2016;118:46-52.
    PubMed     Text format     Abstract available


  51. SELGE C, Thomas S, Nowak D, Radon K, et al
    Asthma prevalence in German Olympic athletes: A comparison of winter and summer sport disciplines.
    Respir Med. 2016;118:15-21.
    PubMed     Text format     Abstract available


  52. SUAREZ-MEDINA R, Venero-Fernandez SJ, Britton J, Fogarty AW, et al
    Population-based weight loss and gain do not explain trends in asthma mortality in Cuba: A prospective study from 1964 to 2014.
    Respir Med. 2016;118:4-6.
    PubMed     Text format     Abstract available


  53. TAN JH, Hsu AA
    Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
    Respir Med. 2016;118:1-3.
    PubMed     Text format     Abstract available


    August 2016
  54. MATULONGA B, Rava M, Siroux V, Bernard A, et al
    Women using bleach for home cleaning are at increased risk of non-allergic asthma.
    Respir Med. 2016;117:264-71.
    PubMed     Text format     Abstract available


  55. BECERRA MB, Becerra BJ, Teodorescu M
    Healthcare burden of obstructive sleep apnea and obesity among asthma hospitalizations: Results from the U.S.-based Nationwide Inpatient Sample.
    Respir Med. 2016;117:230-6.
    PubMed     Text format     Abstract available


  56. TUOMISTO LE, Ilmarinen P, Niemela O, Haanpaa J, et al
    A 12-year prognosis of adult-onset asthma: Seinajoki Adult Asthma Study.
    Respir Med. 2016;117:223-9.
    PubMed     Text format     Abstract available


  57. KERSTJENS HA, Moroni-Zentgraf P, Tashkin DP, Dahl R, et al
    Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status.
    Respir Med. 2016;117:198-206.
    PubMed     Text format     Abstract available


  58. RADHAKRISHNA N, Tay TR, Hore-Lacy F, Hoy R, et al
    Profile of difficult to treat asthma patients referred for systematic assessment.
    Respir Med. 2016;117:166-73.
    PubMed     Text format     Abstract available


  59. NAQVI M, Khachi H
    The barriers to accessing primary care resulting in hospital presentation for exacerbation of asthma or chronic obstructive pulmonary disease in a large teaching hospital in London.
    Respir Med. 2016;117:162-5.
    PubMed     Text format     Abstract available


  60. LICCARDI G, Salzillo A, Calzetta L, Cazzola M, et al
    Can bronchial asthma with an highly prevalent airway (and systemic) vagal tone be considered an independent asthma phenotype? Possible role of anticholinergics.
    Respir Med. 2016;117:150-3.
    PubMed     Text format     Abstract available


  61. GORSKA K, Korczynski P, Mierzejewski M, Kosciuch J, et al
    Comparison of endobronchial ultrasound and high resolution computed tomography as tools for airway wall imaging in asthma and chronic obstructive pulmonary disease.
    Respir Med. 2016;117:131-8.
    PubMed     Text format     Abstract available


  62. KOSKELA HO, Purokivi MK, Kokkarinen J
    Stepping down from combination asthma therapy: The predictors of outcome.
    Respir Med. 2016;117:109-15.
    PubMed     Text format     Abstract available


  63. KJELLBERG S, Houltz BK, Zetterstrom O, Robinson PD, et al
    Clinical characteristics of adult asthma associated with small airway dysfunction.
    Respir Med. 2016;117:92-102.
    PubMed     Text format     Abstract available


    July 2016
  64. MIRABELLI MC, Hsu J, Gower WA
    Comorbidities of asthma in U.S. children.
    Respir Med. 2016;116:34-40.
    PubMed     Text format     Abstract available


  65. USMANI OS, Singh D, Spinola M, Bizzi A, et al
    The prevalence of small airways disease in adult asthma: A systematic literature review.
    Respir Med. 2016;116:19-27.
    PubMed     Text format     Abstract available


    June 2016
  66. BUHL R, Korn S, Menzies-Gow A, Aubier M, et al
    Assessing biomarkers in a real-world severe asthma study (ARIETTA).
    Respir Med. 2016;115:7-12.
    PubMed     Text format     Abstract available


  67. OHRMALM L, Malinovschi A, Wong M, Levinson P, et al
    Presence of rhinovirus in the respiratory tract of adolescents and young adults with asthma without symptoms of infection.
    Respir Med. 2016;115:1-6.
    PubMed     Text format     Abstract available


    May 2016
  68. HEFFLER E, Crimi N
    Asthma control and bronchodilator response.
    Respir Med. 2016 May 15. pii: S0954-6111(16)30096.
    PubMed     Text format    


  69. RAJAURE Y, Kumar B, Sahoo K, T V, et al
    Bronchodilator response not a significant marker of poor asthma control.
    Respir Med. 2016 May 10. pii: S0954-6111(16)30076.
    PubMed     Text format    


    March 2016
  70. ONATIBIA-ASTIBIA A, Martinez-Pinilla E, Franco R
    The potential of methylxanthine-based therapies in pediatric respiratory tract diseases.
    Respir Med. 2016;112:1-9.
    PubMed     Text format     Abstract available


  71. DISANTOSTEFANO RL, Hinds D, Le HV, Barnes NC, et al
    Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort.
    Respir Med. 2016;112:88-96.
    PubMed     Text format     Abstract available


  72. STELMACH I, Cichalewski L, Majak P, Smejda K, et al
    School environmental factors are predictive for exercise-induced symptoms in children.
    Respir Med. 2016;112:25-30.
    PubMed     Text format     Abstract available


    February 2016
  73. VAN DER EYCKEN S, Schelpe A, Marijsse G, Dilissen E, et al
    Feasibility to apply eucapnic voluntary hyperventilation in young elite athletes.
    Respir Med. 2016;111:91-3.
    PubMed     Text format     Abstract available


    January 2016
  74. MAIO S, Baldacci S, Carrozzi L, Pistelli F, et al
    Respiratory symptoms/diseases prevalence is still increasing: a 25-yr population study.
    Respir Med. 2016;110:58-65.
    PubMed     Text format     Abstract available


    September 2015
  75. LOWES D, Chishimba L, Greaves M, Denning DW, et al
    Development of chronic pulmonary aspergillosis in adult asthmatics with ABPA.
    Respir Med. 2015 Sep 12. pii: S0954-6111(15)30055.
    PubMed     Text format     Abstract available


    August 2015
  76. VISSER R, Wind M, de Graaf BJ, de Jongh FH, et al
    The effect of body posture during medication inhalation on exercise induced bronchoconstriction in asthmatic children.
    Respir Med. 2015 Aug 29. pii: S0954-6111(15)30044.
    PubMed     Text format     Abstract available


    July 2015
  77. VISSER R, Kelderman S, de Jongh FH, van der Palen J, et al
    Reversibility of pulmonary function after inhaling salbutamol in different doses and body postures in asthmatic children.
    Respir Med. 2015 Jul 23. pii: S0954-6111(15)30030.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: